Search Results
Clinical Trial Participant 'Biogen's Aducanumab Was Working' | Patient Perspectives | Being Patient
An Alzheimer's Trial Gave Them Hope—Until It Was Canceled | Patient Perspectives | Being Patient
'I Felt Like the Drug Was Working' - First Patient Receives Biogen's Alzheimer's Drug in New Trial
Experts responds to fda approval of aducanumab | Being Patient
'How Does It Feel to Be Number One?' First Patient Receives Biogen's Alzheimer's Drug in New Trial
Experts Respond to the FDA’s Approval of Aducanumab | LiveTalk | Being Patient
Alzheimer’s Disease Clinical Trial Participants: Thank You
Will Aducanumab Be The Next Treatment for Alzheimer's Disease
Howard Fillit, MD: Aducanumab Findings Lead the Way in Dementia
Biogen to seek FDA approval for Alzheimer's drug Aducanumab
Practice Perspectives for Aducanumab - American Academy of Neurology
What Does an Alzheimer's Drug Relaunch Mean For A Cure? | Brain Talks | Being Patient
